Linezolid for Syphilis Pilot Study

Status Recruiting

Clinical Trial Summary

The study aims to evaluate the efficacy of linezolid for the treatment of syphilis.

Clinical Trial Description

This will be a randomized, open-label, non-comparative, adaptive pilot trial to evaluate the efficacy of linezolid 600mg orally, twice a day, for five or ten days, using a contemporaneous historical control group benzathine penicillin G (single dose of 2.4 million units) in participants with and without HIV infection. In total, 24 participants will be enrolled across multiple clinical sites in the United States. Participants will participate in follow-ups to monitor clinical outcomes and serological response (RPR titer) at 1 month, 3 months, and 6 months. Study findings may identify an efficacious alternative syphilis treatment to penicillin that is effective for people living with HIV. Study findings may also help address the crisis of penicillin shortages, difficulty in administration, and offer options for those with penicillin allergy. ;

Study Design

Related Conditions & MeSH terms

Syphilis

Clinical Trial Details

NCT number	NCT05548426
Study type	Interventional
Source	University of Southern California
Contact	Jeffrey D Klausner, MD MPH
Phone	(415) 876-8901
Email	jdklausner@med.usc.edu
Status	Recruiting
Phase	Phase 2
Start date	September 28, 2023
Completion date	March 2025

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03660488` - Cefixime for Alternative Syphilis Treatment	Phase 2
Completed	`NCT02191527` - Evaluating the Effectiveness of Point-of-care Diagnostic Technologies in MCH Services in Mozambique	N/A
Completed	`NCT01439503` - Safer Sex Program for Young African-American Men	Phase 2
Terminated	`NCT01540227` - Penicillin Therapeutic Drug Monitoring in the Treatment of Infectious Syphilis.
Completed	`NCT02257658` - Efficacy of Doxycycline Prophylaxis to Reduce Syphilis in High-Risk, HIV-Positive MSM	N/A
Completed	`NCT02611765` - Syphilis Response to Higher Penicillin Dosage: The 2.4 Versus 7.2 Study	Phase 4
Not yet recruiting	`NCT06428643` - A Seek, Test, and Treat Intervention to Reduce Chlamydia Trachomatis Disparities	N/A
Completed	`NCT03709862` - Global Syphilis Sequencing
Completed	`NCT03637660` - Phase 4 Comparative Trial of Benzathine Penicillin G for Treatment of Early Syphilis in Subjects With or Without HIV Infection	Phase 4
Active, not recruiting	`NCT03310424` - Transcriptomic and Next Generation Sequencing Approaches to Infection With Treponema Pallidum
Completed	`NCT00207506` - Lay Health Advisors for Sexually Transmitted Disease Prevention	Phase 1/Phase 2
Completed	`NCT00213018` - Safety, Acceptability and Preliminary Effectiveness of Carraguard™ (PC-515) in Preventing HIV/STI Transmission	Phase 2
Recruiting	`NCT06059443` - mLab App Plus: A Randomized Controlled Trial of a Mobile Health (mHealth) Intervention	N/A
Completed	`NCT04480749` - Syphilis Self-testing to Expand Test Uptake Among Men Who Have Sex With Men (SST)	Phase 4
Not yet recruiting	`NCT06058286` - MENJAGA: Continuous Quality Improvement for Antenatal HIV, Syphilis and Hepatitis B Testing in Indonesia	N/A
Active, not recruiting	`NCT03980223` - Evaluation of Doxycycline Post-exposure Prophylaxis to Reduce Sexually Transmitted Infections in PrEP Users and HIV-infected Men Who Have Sex With Men	Phase 4
Completed	`NCT01465607` - Implementation of an Efficacious Intervention for High Risk Women in Mexico	N/A
Completed	`NCT00553111` - Video Tool to Promote Knowledge of Syphilis as Facilitator of HIV Transmission	N/A
Active, not recruiting	`NCT06367621` - Retrospective Study of iStatis Syphilis Ab Test (POC)
Completed	`NCT02445846` - Dual Rapid HIV & Syphilis Tests in Zambia	N/A